OpenVSafe by OpenVAERS
Search V-safe

XER-33439-42296

3 vaccinations 8 coded responses 39 check-ins 7 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
535 / WI
Registered
2021-01-23
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-23
    Registered in v-safe
  2. 2021-01-23
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-23
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-01-24
    Survey response — days 1–6 daily, dose 1
    MedDRA: Rhinorrhoea — Feeling: Good · Site: Pain
    Free text: Runny nose
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-30
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-02-06
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-02-13
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-02-14
    Dose 2 — Pfizer-BioNTech
  13. 2021-02-14
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  14. 2021-02-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  15. 2021-02-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  16. 2021-02-17
    Survey response — days 1–6 daily, dose 2
    MedDRA: Rhinorrhoea — Feeling: Good · Site: Pain
    Free text: Runny nose
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-02-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-02-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-02-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-02-21
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-02-28
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-07
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-14
    Survey response — day 28, dose 2
    MedDRA: Rhinorrhoea — Feeling: Good
    Free text: Runny nose
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-03-21
    Survey response — day 35, dose 2
    MedDRA: Nasal congestion, Nasopharyngitis, Rhinorrhoea — Feeling: Good
    Free text: Developed cold like symptoms. Extra mucus, stuffy nose.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-03-28
    Survey response — day 42, dose 2
    MedDRA: Dysphonia, Nasal congestion, Nasopharyngitis — Feeling: Good
    Free text: Stuffy nose, hoarse voice, cold-like symptoms
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  26. 2021-05-16
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-08-15
    Survey response — 6 months, dose 2
    MedDRA: Injection site pain — Feeling: Good
    Free text: Pain at injection site
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  28. 2022-02-14
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  29. 2022-04-20
    Dose 3 — Pfizer-BioNTech
  30. 2022-04-21
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  31. 2022-04-22
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  32. 2022-04-23
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  33. 2022-04-24
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  34. 2022-04-25
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  35. 2022-04-29
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  36. 2022-05-04
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  37. 2022-05-11
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  38. 2022-05-18
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  39. 2022-05-25
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  40. 2022-06-01
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  41. 2022-07-20
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  42. 2022-10-19
    Survey response — 6 months, dose 3
    MedDRA: Nasopharyngitis, Pre-existing disease, Respiratory symptom — Feeling: Good
    Free text: Fall allergies, common cold/upper respiratory symptoms.
    MedDRA releases: 2024-11 · check-in free text available
  43. 2023-04-20
    Survey response — 12 months, dose 3
    MedDRA: Pharyngitis streptococcal — Feeling: Good · Be unable to do your normal daily activities
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-01-23Pfizer-BioNTech
22021-02-14Pfizer-BioNTech
32022-04-20Pfizer-BioNTech No

Free text

Release 2 — days 1–6 daily, dose 1

2021-01-24

Systemic reaction (other): Runny nose

Release 4 — days 1–6 daily, dose 2

2021-02-17

Systemic reaction (other): Runny nose

Release 5 — day 28, dose 2

2021-03-14

Symptoms: Runny nose

Release 6 — day 35, dose 2

2021-03-21

Symptoms: Developed cold like symptoms. Extra mucus, stuffy nose.

Release 6 — day 42, dose 2

2021-03-28

Symptoms: Stuffy nose, hoarse voice, cold-like symptoms

Release 9 — 6 months, dose 2

2021-08-15

Symptoms: Pain at injection site

Release 12 — 6 months, dose 3

2022-10-19

Symptoms: Fall allergies, common cold/upper respiratory symptoms.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDDysphonia ✓ ✓ ✓
SDInjection site pain ✓ · ✓
SDNasal congestion ✓ ✓ ✓
SDNasopharyngitis ✓ ✓ ✓
SDPharyngitis streptococcal · · ✓
SDPre-existing disease · · ✓
SDRespiratory symptom · · ✓
SDRhinorrhoea ✓ ✓ ✓
SRORhinorrhoea ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release